PR Newswire
NEW YORK
,
Jan. 1, 2023
/PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against EyePoint Pharmaceuticals (“Eyepoint” or the “Company”) (NASDAQ: EYPT).
If you suffered losses exceeding
$50,000
investing in Eyepoint stock or options
and would like to discuss your legal rights, call Faruqi & Faruqi partner
Josh Wilson
directly
at
877-247-4292
or
212-983-9330
(Ext. 1310)
. You may also click here for additional information:
www.faruqilaw.com/EYPT
.
There is no cost or obligation to you.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in
New York
,
Pennsylvania
,
California
and
Georgia
.
EyePoint Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company specializes in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. EyePoint Pharmaceuticals serves customers worldwide.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (
www.faruqilaw.com
). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
View original content to download multimedia:
https://www.prnewswire.com/news-releases/eyepoint-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50-000-in-eyepoint-to-contact-him-directly-to-discuss-their-options-301710324.html
SOURCE Faruqi & Faruqi, LLP
